Amelenodor

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H21N3O3
Molecular Weight	399.4418
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of Amelenodor

Structure Search

SMILES

CC1=CC=CC(OC2=CC(OC3=CC=CC(C)=N3)=CC(OC4=CC=CC(C)=N4)=C2)=N1

InChI

InChIKey=OPUQKVNCXCWRLR-UHFFFAOYSA-N

InChI=1S/C24H21N3O3/c1-16-7-4-10-22(25-16)28-19-13-20(29-23-11-5-8-17(2)26-23)15-21(14-19)30-24-12-6-9-18(3)27-24/h4-15H,1-3H3

HIDE SMILES / InChI

Molecular Formula	C24H21N3O3
Molecular Weight	399.4418
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 08:10:07 GMT 2025` Edited by `admin` on `Wed Apr 02 08:10:07 GMT 2025`
Record UNII	DVH35H3HDB
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Amelenodor

Official Name

English

NX-13 FREE BASE

Preferred Name

English

amelenodor [INN]

Common Name

English

2,2',2''-[benzene-1,3,5-triyltris(oxy)]tris(6-methylpyridine)

Systematic Name

English

Pyridine, 2,2?,2??-[1,3,5-benzenetriyltris(oxy)]tris[6-methyl-

Systematic Name

English

2,2',2''-[1,3,5-Benzenetriyltris(oxy)]tris[6-methylpyridine

Systematic Name

English

1,3,5-tris((6-methylpyridin-2-yl)oxy)benzene

Systematic Name

English

Code System Code Type Description

CAS

2389235-01-0

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

SMS_ID

300000033522

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

PUBCHEM

146651362

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

NCI_THESAURUS

C190433

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

FDA UNII

DVH35H3HDB

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

INN

12306

Created by admin on Wed Apr 02 08:10:07 GMT 2025 , Edited by admin on Wed Apr 02 08:10:07 GMT 2025

PRIMARY

Related Record Type Details


					IMM4OP954P

NLR FAMILY MEMBER X1

TARGET -> AGONIST

Amount:

Related Record Type Details


					DVH35H3HDB

ACTIVE MOIETY

Comments:

NX-13 has potent anti-inflammatory effects through the downregulation of inflammatory mediators and cell types and maintenance of barrier function in GI epithelial cells.

Amount: